GeoVax Labs Inc (GOVX)

NASDAQ HEALTHCARE

$2.06 -14.17% RSI 53 Neutral Add Alert

Moving Averages

SMA 200

$8.59

Price below

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$4.28M

P/E Ratio

None

EPS

$-22.4

Beta

3.353